Skip to main content

NUEVOS METODOS PARA LA EFICIENCIA Y SEGURIDAD DEL PANCREAS ARTIFICIAL DOMICILIARIO EN DIABETES TIPO 1

DPI2013-46982-C2-2-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2013
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre UNIVERSITAT DE GIRONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Validation of a FBA model for Pichia pastoris in chemostat cultures

  • Morales, Yeimy
  • Tortajada, Marta
  • Vehi, Josep
  • Picó, Jesús|||0000-0003-4144-3521
  • Llaneras, Francisco
Background: Constraint-based metabolic models and flux balance analysis (FBA) have been extensively used in the last years to investigate the behavior of cells and also as basis for different industrial applications. In this context, this work provides a validation of a small-sized FBA model of the yeast Pichia pastoris. Our main objective is testing how accurate is the hypothesis of maximum growth to predict the behavior of P. pastoris in a range of experimental environments. Results: A constraint-based model of P. pastoris was previously validated using metabolic flux analysis (MFA). In this paper we have verified the model ability to predict the cells behavior in different conditions without introducing measurements, experimental parameters, or any additional constraint, just by assuming that cells will make the best use of the available resources to maximize its growth. In particular, we have tested FBA model ability to: (a) predict growth yields over single substrates (glucose, glycerol, and methanol); (b) predict growth rate, substrate uptakes, respiration rates, and by-product formation in scenarios where different substrates are available (glucose, glycerol, methanol, or mixes of methanol and glycerol); (c) predict the different behaviors of P. pastoris cultures in aerobic and hypoxic conditions for each single substrate. In every case, experimental data from literature are used as validation. Conclusions: We conclude that our predictions based on growth maximisation are reasonably accurate, but still far from perfect. The deviations are significant in scenarios where P. pastoris grows on methanol, suggesting that the hypothesis of maximum growth could be not dominating in these situations. However, predictions are much better when glycerol or glucose are used as substrates. In these scenarios, even if our FBA model is small and imposes a strong assumption regarding how cells will regulate their metabolic fluxes, it provides reasonably good predictions in terms of growth, substrate preference, product formation, and respiration rates, This research has been partially supported by the Spanish Government (cicyt: DPI 2011-28112-C04-01, DPI 2013-46982-C2-2-R) and Biopolis S.L. (R.C.055/12). Yeimy Morales is grateful for the BR Grant of the University of Girona (BR2012/26). The authors are grateful to the company Biopolis S.L. for his support to this research.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target

  • Rossetti, P.
  • Quirós, C.
  • Moscardo-Garcia, Vanessa
  • Comas, A.
  • Giménez, M.
  • Ampudia-Blasco, F.J.
  • León, F.
  • Montaser Roushdi Ali, Eslam
  • Conget, I.
  • Vehí, J.
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: Postprandial (PP) control remains a challenge for closed-loop (CL) systems. Few studies with inconsistent results have systematically investigated the PP period. Objective: To compare a new CL algorithm with current pump therapy (open loop [OL]) in the PP glucose control in type 1 diabetes (T1D) subjects. Methods: A crossover randomized study was performed in two centers. Twenty T1D subjects (F/M 13/7, age 40.7 -10.4 years, disease duration 22.6 +/- 9.9 years, and A1c 7.8% +/- 0.7%) underwent an 8-h mixed meal test on four occasions. In two (CL1/CL2), after meal announcement, a bolus was given followed by an algorithmdriven basal infusion based on continuous glucose monitoring (CGM). Alternatively, in OL1/OL2 conventional pump therapy was used. Main outcome measures were as follows: glucose variability, estimated with the coefficient of variation (CV) of the area under the curve (AUC) of plasma glucose (PG) and CGM values, and from the analysis of the glucose time series; mean, maximum (C-max), and time to C-max glucose concentrations and time in range (<70, 70-180, >180 mg/dL). Results: CVs of the glucose AUCs were low and similar in all studies (around 10%). However, CL achieved greater reproducibility and better PG control in the PP period: CL1 = CL2<OL1<OL2 (PG(mean) 123 +/- 47 and 125 +/- 44 vs. 152 +/- 53 and 159 +/- 54 mg/dL) and C-max OL 217.1 +/- 67.0 mg/dL versus CL 183.3 +/- 63.9 mg/dL, P < 0.0001. Time-in-range was higher with CL versus OL (80% vs. 64%; P < 0.001). Neither the time below 70 mg/dL (CL 6.1% vs. OL 3.2%; P > 0.05) nor the need for oral glucose was significantly different (CL 40.0% vs. OL 22.5% of meals; P = 0.054). Conclusions: This novel CL algorithm effectively and consistently controls PP glucose excursions without increasing hypoglycemia. Study registered at ClinicalTrials.gov: study number NCT02100488., This work was supported by the Spanish Ministry of Economy and Competitiveness through Grants DPI2013-46982-C2-1-R and DPI2013-46982-C2-2-R, and the EU through FEDER funds. C.Q. is the recipient of a grant from the Hospital Clinic i Universitari of Barcelona ("Ajut a la recerca Josep Font 2014-2017").
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Extensive assessment of blood glucose monitoring during postprandial period and its impact on closed-loop performance

  • Biagi, L.
  • Hirata-Bertachi, A.
  • Conget, I.
  • Quirós, C.
  • Giménez, M.
  • Ampudia-Blasco, F.J.
  • Rossetti, P.
  • Vehí, J.
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: Closed-loop (CL) systems aims to outperform usual treatments in blood glucose control and continuous glucose monitors (CGM) are a key component in such systems. Meals represents one of the main disturbances in blood glucose control, and postprandial period (PP) is a challenging situation for both CL system and CGM accuracy. Methods: We performed an extensive analysis of sensor¿s performance by numerical accuracy and precision during PP, as well as its influence in blood glucose control under CL therapy. Results: During PP the mean absolute relative difference (MARD) for both sensors presented lower accuracy in the hypoglycemic range (19.4 ± 12.8%) than in other ranges (12.2 ± 8.6% in euglycemic range and 9.3 ± 9.3% in hyperglycemic range). The overall MARD was 12.1 ± 8.2%. We have also observed lower MARD for rates of change between 0 and 2 mg/dl. In CL therapy, the 10 trials with the best sensor spent less time in hypoglycemia (PG < 70 mg/dl) than the 10 trials with the worst sensors (2 ± 7 minutes vs 32 ± 38 minutes, respectively). Conclusions: In terms of accuracy, our results resemble to previously reported. Furthermore, our results showed that sensors with the lowest MARD spent less time in hypoglycemic range, indicating that the performance of CL algorithm to control PP was related to sensor accuracy., The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project has been partially supported by the Spanish Government through Grants DPI 2013-46982-C2-1-R, DPI 2016-78831-C2-1-R, DPI 2013-46982-C2-2-R, and DPI 2016-78831-C2-2-R, the National Council of Technological and Scientific Development, CNPq Brazil through Grants 202050/2015-7 and 207688/2014-1.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Accuracy of Continuous Glucose Monitoring before, during, and after Aerobic and Anaerobic Exercise in Patients with Type 1 Diabetes Mellitus

  • Biagi, L.
  • Bertachi, A.
  • Quirós, C.
  • Giménez, M.
  • Conget, I.
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Continuous glucose monitoring (CGM) plays an important role in treatment decisions for patients with type 1 diabetes under conventional or closed-loop therapy. Physical activity represents a great challenge for diabetes management as well as for CGM systems. In this work, the accuracy of CGM in the context of exercise is addressed. Six adults performed aerobic and anaerobic exercise sessions and used two Medtronic Paradigm Enlite-2 sensors under closed-loop therapy. CGM readings were compared with plasma glucose during different periods: one hour before exercise, during exercise, and four hours after the end of exercise. In aerobic sessions, the median absolute relative difference (MARD) increased from 9.5% before the beginning of exercise to 16.5% during exercise (p < 0.001), and then decreased to 9.3% in the first hour after the end of exercise (p < 0.001). For the anaerobic sessions, the MARD before exercise was 15.5% and increased without statistical significance to 16.8% during exercise realisation (p = 0.993), and then decreased to 12.7% in the first hour after the cessation of anaerobic activities (p = 0.095). Results indicate that CGM might present lower accuracy during aerobic exercise, but return to regular operation a few hours after exercise cessation. No significant impact for anaerobic exercise was found., This project was partially supported by the Spanish Government through grants DPI2013-46982-C2-1-R, DPI2013-46982-C2-2-R, DPI2016-78831-C2-1-R, and DPI2016-78831-C2-2-R, and by the National Council of Technological and Scientific Development, CNPq Brazil through grants 202050/2015-7 and 207688/2014-1.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target

  • Rossetti, Paolo
  • Quirós, Carmen
  • Moscardó, Vanessa
  • Comas, Anna
  • Giménez, Marga
  • Ampudia-Blasco, Francisco Javier
  • León Vargas, Fabian Mauricio
  • Montaser, Eslam
  • Conget, Ignacio
  • Bondia, Jorge
  • Vehí, Josep
Background: Postprandial (PP) control remains a challenge for closed-loop (CL) systems. Few studies with inconsistent results have systematically investigated the PP period. Objective: To compare a new CL algorithm with current pump therapy (open loop [OL]) in the PP glucose control in type 1 diabetes (T1D) subjects. Methods: A crossover randomized study was performed in two centers. Twenty T1D subjects (F/M 13/7, age 40.7 ± 10.4 years, disease duration 22.6 ± 9.9 years, and A1c 7.8% ± 0.7%) underwent an 8-h mixed meal test on four occasions. In two (CL1/CL2), after meal announcement, a bolus was given followed by an algorithm-driven basal infusion based on continuous glucose monitoring (CGM). Alternatively, in OL1/OL2 conventional pump therapy was used. Main outcome measures were as follows: glucose variability, estimated with the coefficient of variation (CV) of the area under the curve (AUC) of plasma glucose (PG) and CGM values, and from the analysis of the glucose time series; mean, maximum (Cmax), and time to Cmax glucose concentrations and time in range (<70, 70–180, >180 mg/dL). Results: CVs of the glucose AUCs were low and similar in all studies (around 10%). However, CL achieved greater reproducibility and better PG control in the PP period: CL1 = CL2<OL1<OL2 (PGmean 123 ± 47 and 125 ± 44 vs. 152 ± 53 and 159 ± 54 mg/dL) and Cmax OL 217.1 ± 67.0 mg/dL versus CL 183.3 ± 63.9 mg/dL, P < 0.0001. Time-in-range was higher with CL versus OL (80% vs. 64%; P < 0.001). Neither the time below 70 mg/dL (CL 6.1% vs. OL 3.2%; P > 0.05) nor the need for oral glucose was significantly different (CL 40.0% vs. OL 22.5% of meals; P = 0.054). Conclusions: This novel CL algorithm effectively and consistently controls PP glucose excursions without increasing hypoglycemia. Study registered at ClinicalTrials.gov: study number NCT02100488, This work was supported by the Spanish Ministry of Economy and Competitiveness through grants DPI2013-46982-C2-1-R and DPI2013-46982-C2-2-R, and the EU through FEDER funds. C.Q. is the recipient of a grant from the Hospital Clínic i Universitari of Barcelona (“Ajut a la recerca Josep Font 2014-2017”)
Recercat. Dipósit de la Recerca de Catalunya
Publication Contribución de congreso (ConferenceOutput)

A Novel Meal Detection Algorithm for an Artificial Pancreas [Pòster]

  • Ramkissoon, Charrise Mary
  • Herrero i Viñas, Pau
  • Bondia, Jorge
  • Vehí, Josep
Pòster de congrés presentat a: 10th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2017), celebrat a París del 15 al 18 de febrer de 2017, Postprandial glucose fluctuations are a challenge to daytime closed-loop control1,2 in type 1 diabetes (T1D). It is predicted that the high number of missed meal boluses experienced during insulin pump therapy3 will carry over to artificial pancreas therapy. Therefore, a means to reduce poor outcomes due to unannounced meals must be developed. The aim of this study is to implement an algorithm to detect meals using data from a continuous glucose monitor (CGM) and the insulin delivered to the subject, DPI2013-46982-1-R/2-R, R, Feder Funds
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A review of personalized blood glucose prediction strategies for T1DM patients

  • Oviedo Castillo, Silvia
  • Vehí, Josep
  • Calm i Puig, Remei
  • Armengol Llobet, Joaquim
This paper presents a methodological review of models for predicting blood glucose (BG) concentration, risks and BG events. The surveyed models are classified into three categories, and they are presented in summary tables containing the most relevant data regarding the experimental setup for fitting and testing each model as well as the input signals and the performance metrics. Each category exhibits trends that are presented and discussed. This document aims to be a compact guide to determine the modeling options that are currently being exploited for personalized BG prediction, This work has been funded by the Spanish Government through the predoctoral contract ES‐2014‐068289 within the project ‘New methods for efficiency and safety of home artificial pancreas in type I diabetes’ with reference number DPI2013‐46982‐C2‐2‐R
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Using Normalised Compression Distance to Identify Different Profiling Days in Type 1 Diabetic Patients

  • Contreras, Ivan
  • Vehí, Josep
This work is devoted to providing patients and physicians with a novel tool to analyse and extract information for better management of type I diabetes. We use a clustering methodology based on the normalised compression distance to identify different profiles of days. The methodology has been validated using data generated by a simulator of virtual patients, which include an exercise model. Profiling daily data can help physicians and patients cope with information overload and assist in future planning for improved treatments and self-management of diabetes type 1, Partially supported by the Spanish Ministry of Science and Innovation through grant DPI 2013-46982-C2-2-R and the Government of Catalonia trough grant SGR14-1052
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Accuracy of Continuous Glucose Monitoring before, during, and after Aerobic and Anaerobic Exercise in Patients with Type 1 Diabetes Mellitus

  • Biagi, Lyvia
  • Bertachi, Arthur Hirata
  • Quirós, Carmen
  • Giménez, Marga
  • Conget, Ignacio
  • Bondia, Jorge
  • Vehí, Josep
Continuous glucose monitoring (CGM) plays an important role in treatment decisions for patients with type 1 diabetes under conventional or closed-loop therapy. Physical activity represents a great challenge for diabetes management as well as for CGM systems. In this work, the accuracy of CGM in the context of exercise is addressed. Six adults performed aerobic and anaerobic exercise sessions and used two Medtronic Paradigm Enlite-2 sensors under closed-loop therapy. CGM readings were compared with plasma glucose during different periods: one hour before exercise, during exercise, and four hours after the end of exercise. In aerobic sessions, the median absolute relative difference (MARD) increased from 9.5% before the beginning of exercise to 16.5% during exercise (p < 0.001), and then decreased to 9.3% in the first hour after the end of exercise (p < 0.001). For the anaerobic sessions, the MARD before exercise was 15.5% and increased without statistical significance to 16.8% during exercise realisation (p = 0.993), and then decreased to 12.7% in the first hour after the cessation of anaerobic activities (p = 0.095). Results indicate that CGM might present lower accuracy during aerobic exercise, but return to regular operation a few hours after exercise cessation. No significant impact for anaerobic exercise was found, This project was partially supported by the Spanish Government through grants DPI2013-46982-C2-1-R, DPI2013-46982-C2-2-R, DPI2016-78831-C2-1-R, and DPI2016-78831-C2-2-R, and by the National Council of Technological and Scientific Development, CNPq Brazil through grants 202050/2015-7 and 207688/2014-1
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Personalized blood glucose prediction: A hybrid approach using grammatical evolution and physiological models

  • Contreras, Ivan
  • Oviedo Castillo, Silvia
  • Vettoretti, Martina
  • Visentin, Roberto
  • Vehí, Josep
The large patient variability in human physiology and the effects of variables such as exercise or meals challenge current prediction modeling techniques. Physiological models are very precise but they are typically complex and specific physiological knowledge is required. In contrast, data-based models allow the incorporation of additional inputs and accurately capture the relationship between these inputs and the outcome, but at the cost of losing the physiological meaning of the model. In this work, we designed a hybrid approach comprising physiological models for insulin and grammatical evolution, taking into account the clinical harm caused by deviations from the target blood glucose by using a penalizing fitness function based on the Clarke error grid. The prediction models were built using data obtained over 14 days for 100 virtual patients generated by the UVA/Padova T1D simulator. Midterm blood glucose was predicted for the 100 virtual patients using personalized models and different scenarios. The results obtained were promising; an average of 98.31% of the predictions fell in zones A and B of the Clarke error grid. Midterm predictions using personalized models are feasible when the configuration of grammatical evolution explored in this study is used. The study of new alternative models is important to move forward in the development of alarm-and-control applications for the management of type 1 diabetes and the customization of the patient’s treatments. The hybrid approach can be adapted to predict short-term blood glucose values to detect continuous glucose-monitoring sensor errors and to estimate blood glucose values when the continuous glucose-monitoring system fails to provide them, This work was partly supported by the Spanish Ministry of Science and Innovation (grants DPI 2013-46982-C2-2-R and DPI2016-78831-C2-2-R), the People program (Marie Sklodowska-Curie Actions) of the European Union Seventh Framework Programme (FP7/2007-2013) with agreement (No. 600388) (TECNIOspring programme) of the REA and the Agencia per a la Competitivitat de L’Empresa (ACCIO´), and by the Spanish Government through contract ES-2014-068289
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Validation of an FBA model for Pichia pastoris in chemostat cultures

  • Morales Pérez, Yeimy Liceth
  • Tortajada, Marta
  • Picó i Marco, Jesús
  • Vehí, Josep
  • Llaneras Estrada, Francisco
Constraint-based metabolic models and flux balance analysis (FBA) have been extensively used in the last years to investigate the behavior of cells and also as basis for different industrial applications. In this context, this work provides a validation of a small-sized FBA model of the yeast Pichia pastoris. Our main objective is testing how accurate is the hypothesis of maximum growth to predict the behavior of P. pastoris in a range of experimental environments. Results: A constraint-based model of P. pastoris was previously validated using metabolic flux analysis (MFA). In this paper we have verified the model ability to predict the cells behavior in different conditions without introducing measurements, experimental parameters, or any additional constraint, just by assuming that cells will make the best use of the available resources to maximize its growth. In particular, we have tested FBA model ability to: (a) predict growth yields over single substrates (glucose, glycerol, and methanol); (b) predict growth rate, substrate uptakes, respiration rates, and by-product formation in scenarios where different substrates are available (glucose, glycerol, methanol, or mixes of methanol and glycerol); (c) predict the different behaviors of P. pastoris cultures in aerobic and hypoxic conditions for each single substrate. In every case, experimental data from literature are used as validation. Conclusions: We conclude that our predictions based on growth maximisation are reasonably accurate, but still far from perfect. The deviations are significant in scenarios where P. pastoris grows on methanol, suggesting that the hypothesis of maximum growth could be not dominating in these situations. However, predictions are much better when glycerol or glucose are used as substrates. In these scenarios, even if our FBA model is small and imposes a strong assumption regarding how cells will regulate their metabolic fluxes, it provides reasonably good predictions in terms of growth, substrate preference, product formation, and respiration rates., This research has been partially supported by the Spanish Government (cicyt: DPI 2011-28112-C04-01, DPI 2013-46982-C2-2-R) and Biopolis S.L. (R.C.055/12). Yeimy Morales is grateful for the BR Grant of the University of Girona (BR2012/26)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Automated blood glucose control in type 1 diabetes: A review of progress and challenges = Control automatizado de la glucosa en la diabetes tipo 1: revisión del progreso y los desafíos

  • Bertachi, Arthur Hirata
  • Ramkissoon, Charrise Mary
  • Bondia, Jorge
  • Vehí, Josep
Since the 2000s, research teams worldwide have been working to develop closedloop (CL) systems able to automatically control blood glucose (BG) levels in patients with type 1 diabetes. This emerging technology is known as artificial pancreas (AP), and its first commercial version just arrived in the market. The main objective of this paper is to present an extensive review of the clinical trials conducted since 2011, which tested various implementations of the AP for different durations under varying conditions. A comprehensive table that contains key information from the selected publications is provided, and the main challenges in AP development and the mitigation strategies used are discussed. The development timelines for different AP systems are also included, highlighting the main evolutions over the clinical trials for each system, Desde los anos ˜ 2000, equipos de investigación de todo el mundo han estado trabajando para desarrollar sistemas de lazo cerrado (LC) capaces de controlar automáticamente los niveles de glucosa en sangre en pacientes con diabetes tipo 1. Esta tecnología emergente se conoce como el páncreas artificial (PA) y la primera versión comercial acaba de llegar al mercado. El objetivo principal de este trabajo es presentar una extensa revisión de los ensayos clínicos realizados desde 2011, en los cuales se han puesto a prueba diversas implementaciones del AP, para diferentes duraciones y bajo diversas condiciones. Presentamos una tabla completa que contiene información clave de las publicaciones seleccionadas y se debaten los principales retos en el desarrollo del páncreas artificial, así como las estrategias de mitigación empleadas. Se incluye también una cronología sobre el desarrollo de los principales sistemas PA destacando las principales evoluciones en los ensayos clínicos, This work has been partially funded by the Spanish Government (DPI 2013-46982-C2-1-R, DPI 2013-46982-C2-2-R, DPI2016-78831-C2-1-R and DPI2016-78831-C2-2-R), the University of Girona (BR2014/51) and the National Counsel of Technological and Scientific Development, CNPq - Brazil (207688/2014-1)
Recercat. Dipósit de la Recerca de Catalunya
Publication Contribución de congreso (ConferenceOutput)

Automatic Detection of Exercise in People with Type 1 Diabetes Using an Unscented Kalman Filter [Pòster]

  • Ramkissoon, Charrise Mary
  • Herrero i Viñas, Pau
  • Bondia, Jorge
  • Georgiou, Pantelis
  • Oliver, Nick
  • Vehí, Josep
Pòster de congrés presentat a: 9th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2016 ), celebrat a Milà (Itàlia), del 3 a 6 de febrer de 2016, Physical activity in type 1 diabetes mellitus has been found to have varying degrees of effect on glycaemic control depending on the type, intensity and duration of the exercise. Such effect is associated with an imbalance between hepatic glucose production and glucose disposal into the muscle, increased insulin sensitivity and impaired counter-regulatory hormonal response. In the context of an artificial pancreas, automatic detection of exercise has the potential to significantly improve glycaemic control. This work aims to develop a new methodology for automatically detecting exercise that only requires data from a continuous glucose monitor (CGM) and the insulin delivered to the subject. Method: The glucose-insulin Minimal Model was extended, by adding an insulin absorption model and an auxiliary parameter used to describe disturbances. Increases in this parameter may indicate meal ingestions whereas decreases may indicate exercise. The disturbance parameter was estimated using an Unscented Kaman Filter. Two thresholds were introduced to detect exercise: a first threshold to indicate the possibility of an abnormal event; and a second threshold, based on an area-under-the-curve, to indicate exercise. The method was tested on data from 7 closed-loop trials including a period of moderate intensity structured exercise. Results: Overall, the results obtained were satisfactory with an average detection time of 22 minutes, accuracy of 96%, sensitivity of 100% and a specificity of 96%. Conclusion: The presented technique has the potential to be a viable approach to detect physical exercise in the context of an artificial pancreas. Improvements and further testing are necessary to confirm such hypothesis (Diabetes Technology & Therapeutics, 2016, vol. 18, núm. S1, https://doi.org/10.1089/dia.2016.2525), This project has been funded by the Spanish Government through grant DPI2013-46982-C2-R and the Wellcome Trust
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Modeling the Error of the Medtronic Paradigm Veo Enlite Glucose Sensor

  • Biagi, Lyvia
  • Ramkissoon, Charrise Mary
  • Facchinetti, Andrea
  • Leal Moncada, Yenny Teresa
  • Vehí, Josep
Continuous glucose monitors (CGMs) are prone to inaccuracy due to time lags, sensor drift, calibration errors, and measurement noise. The aim of this study is to derive the model of the error of the second generation Medtronic Paradigm Veo Enlite (ENL) sensor and compare it with the Dexcom SEVEN PLUS (7P), G4 PLATINUM (G4P), and advanced G4 for Artificial Pancreas studies (G4AP) systems. An enhanced methodology to a previously employed technique was utilized to dissect the sensor error into several components. The dataset used included 37 inpatient sessions in 10 subjects with type 1 diabetes (T1D), in which CGMs were worn in parallel and blood glucose (BG) samples were analyzed every 15 ± 5 min Calibration error and sensor drift of the ENL sensor was best described by a linear relationship related to the gain and offset. The mean time lag estimated by the model is 9.4 ± 6.5 min. The overall average mean absolute relative difference (MARD) of the ENL sensor was 11.68 ± 5.07% Calibration error had the highest contribution to total error in the ENL sensor. This was also reported in the 7P, G4P, and G4AP. The model of the ENL sensor error will be useful to test the in silico performance of CGM-based applications, i.e., the artificial pancreas, employing this kind of sensor, This project has been partially supported by the Spanish Government through Grants DPI-2013-46982-C2-2-R and DPI-2016-78831-C2-2-R, the National Council of Technological and Scientific Development, CNPq Brazil through Grant 202050/2015-7, the University of Girona through Grant BR2014/51, and the Agency for Management of University and Research Grants of the Government of Catalonia, Spain (Beatriu de Pinós [BP-DGR 2013])